T. Rowe Price Associates’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-103,915
| Closed | -$316K | – | 3091 |
|
|
2024
Q4 | $316K | Buy |
103,915
+7,839
| +8% | +$23.8K | ﹤0.01% | 2478 |
|
|
2024
Q3 | $499K | Buy |
96,076
+1,623
| +2% | +$8.43K | ﹤0.01% | 2239 |
|
|
2024
Q2 | $243K | Buy |
94,453
+25,092
| +36% | +$64.6K | ﹤0.01% | 2514 |
|
|
2024
Q1 | $342K | Buy |
69,361
+15,496
| +29% | +$76.4K | ﹤0.01% | 2374 |
|
|
2023
Q4 | $474K | Buy |
53,865
+3,487
| +7% | +$30.7K | ﹤0.01% | 2195 |
|
|
2023
Q3 | $578K | Buy |
50,378
+4,838
| +11% | +$55.5K | ﹤0.01% | 2034 |
|
|
2023
Q2 | $1.15M | Buy |
45,540
+2,747
| +6% | +$69.6K | ﹤0.01% | 1731 |
|
|
2023
Q1 | $1.38M | Sell |
42,793
-572
| -1% | -$18.4K | ﹤0.01% | 1626 |
|
|
2022
Q4 | $801K | Sell |
43,365
-610
| -1% | -$11.3K | ﹤0.01% | 1887 |
|
|
2022
Q3 | $1.19M | Buy |
43,975
+5,643
| +15% | +$152K | ﹤0.01% | 1669 |
|
|
2022
Q2 | $530K | Buy |
38,332
+428
| +1% | +$5.92K | ﹤0.01% | 2196 |
|
|
2022
Q1 | $739K | Buy |
37,904
+5,551
| +17% | +$108K | ﹤0.01% | 2157 |
|
|
2021
Q4 | $528K | Buy |
32,353
+7,608
| +31% | +$124K | ﹤0.01% | 2359 |
|
|
2021
Q3 | $689K | Buy |
24,745
+200
| +0.8% | +$5.57K | ﹤0.01% | 2221 |
|
|
2021
Q2 | $728K | Buy |
24,545
+2,303
| +10% | +$68.3K | ﹤0.01% | 2198 |
|
|
2021
Q1 | $622K | Sell |
22,242
-6,904
| -24% | -$193K | ﹤0.01% | 2257 |
|
|
2020
Q4 | $826K | Buy |
29,146
+6,836
| +31% | +$194K | ﹤0.01% | 2018 |
|
|
2020
Q3 | $561K | Buy |
22,310
+2,610
| +13% | +$65.6K | ﹤0.01% | 2044 |
|
|
2020
Q2 | $481K | Buy |
19,700
+561
| +3% | +$13.7K | ﹤0.01% | 2061 |
|
|
2020
Q1 | $283K | Buy |
19,139
+2,896
| +18% | +$42.8K | ﹤0.01% | 2206 |
|
|
2019
Q4 | $264K | Sell |
16,243
-11,350
| -41% | -$184K | ﹤0.01% | 2347 |
|
|
2019
Q3 | $359K | Buy |
27,593
+247
| +0.9% | +$3.21K | ﹤0.01% | 2219 |
|
|
2019
Q2 | $355K | Buy |
27,346
+139
| +0.5% | +$1.8K | ﹤0.01% | 2243 |
|
|
2019
Q1 | $429K | Buy |
27,207
+13,362
| +97% | +$211K | ﹤0.01% | 2169 |
|
|
2018
Q4 | $279K | Buy |
+13,845
| New | +$279K | ﹤0.01% | 2306 |
|